Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis

Detalhes bibliográficos
Autor(a) principal: Silva, Magnus R Dias da [UNIFESP]
Data de Publicação: 2002
Outros Autores: Cerutti, Janete Maria [UNIFESP], Tengan, Celia Harumi [UNIFESP], Furuzawa, Gilberto Koiti [UNIFESP], Vieira, Teresa C. Alfinito [UNIFESP], Gabbai, Alberto Alain [UNIFESP], Maciel, Rui Monteiro de Barros [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1046/j.1365-2265.2002.01481.x
http://repositorio.unifesp.br/handle/11600/43358
Resumo: OBJECTIVE To investigate whether patients with thyrotoxic hypokalaemic periodic paralysis (THPP) have the same molecular defect in the calcium channel gene described in familial hypokalaemic periodic paralysis (FHPP), as the symptoms of both diseases are comparable, we analysed, in patients with THPP, the presence of mutations R528H, R1239H and R1239G on the S-4 voltage-sensing transmembrane segment of the alpha1 subunit of the calcium channel gene (Cav1.1).DESIGN AND PATIENTS Genomic DNA was extracted from peripheral blood from 14 patients with THPP, 13 sporadic cases and one with a family history. An FHPP family was selected as a positive control. The exons bearing the described mutations were amplified by PCR, screened by single-strand conformation polymorphism (SSCP), and further sequenced.MEASUREMENTS THPP was diagnosed both clinically and through laboratory tests, all patients having elevated levels of thyroid hormones (T4, T3 or free T4), suppressed TSH and plasma potassium below 3.5 mmol/l.RESULTS No evidence of the described mutations was found in patients with THPP. Furthermore, we did not detect any mutations in any of the four full S-4 voltage-sensing transmembrane segments of Cav1.1 (DIS4, DIIS4, DIIIS4 and DIVS4) by direct sequencing. However, close to the R528H mutation, we identified two single nucleotide polymorphisms at nucleotides 1551 and 1564 in both familial and sporadic cases with THPP. In addition, we were able to detect the R528H mutation in the DIIS4 transmembrane segment in all members of the FHPP family.CONCLUSION Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. However, polymorphisms in nucleotides 1551 and 1564 in the exon 11 were found in patients with familial hypokalaemic periodic paralysis and thyrotoxic hypokalaemic periodic paralysis in higher frequency than in controls. The polymorphisms identified within the Cav1.1 gene are associated with thyrotoxic hypokalaemic periodic paralysis and represent a novel finding.
id UFSP_66d0385ae4bb02757eb3fedf205f23be
oai_identifier_str oai:repositorio.unifesp.br/:11600/43358
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysisOBJECTIVE To investigate whether patients with thyrotoxic hypokalaemic periodic paralysis (THPP) have the same molecular defect in the calcium channel gene described in familial hypokalaemic periodic paralysis (FHPP), as the symptoms of both diseases are comparable, we analysed, in patients with THPP, the presence of mutations R528H, R1239H and R1239G on the S-4 voltage-sensing transmembrane segment of the alpha1 subunit of the calcium channel gene (Cav1.1).DESIGN AND PATIENTS Genomic DNA was extracted from peripheral blood from 14 patients with THPP, 13 sporadic cases and one with a family history. An FHPP family was selected as a positive control. The exons bearing the described mutations were amplified by PCR, screened by single-strand conformation polymorphism (SSCP), and further sequenced.MEASUREMENTS THPP was diagnosed both clinically and through laboratory tests, all patients having elevated levels of thyroid hormones (T4, T3 or free T4), suppressed TSH and plasma potassium below 3.5 mmol/l.RESULTS No evidence of the described mutations was found in patients with THPP. Furthermore, we did not detect any mutations in any of the four full S-4 voltage-sensing transmembrane segments of Cav1.1 (DIS4, DIIS4, DIIIS4 and DIVS4) by direct sequencing. However, close to the R528H mutation, we identified two single nucleotide polymorphisms at nucleotides 1551 and 1564 in both familial and sporadic cases with THPP. In addition, we were able to detect the R528H mutation in the DIIS4 transmembrane segment in all members of the FHPP family.CONCLUSION Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. However, polymorphisms in nucleotides 1551 and 1564 in the exon 11 were found in patients with familial hypokalaemic periodic paralysis and thyrotoxic hypokalaemic periodic paralysis in higher frequency than in controls. The polymorphisms identified within the Cav1.1 gene are associated with thyrotoxic hypokalaemic periodic paralysis and represent a novel finding.Univ Fed Sao Paulo, Escola Paulista Med, Dept Med, Div Endocrinol,Lab Mol Endocrinol, BR-04039032 Sao Paulo, BrazilUniv Fed Sao Paulo, Escola Paulista Med, Dept Neurol, Div Endocrinol,Lab Mol Endocrinol, BR-04039032 Sao Paulo, BrazilUniv Fed Sao Paulo, Escola Paulista Med, Dept Med, Div Endocrinol,Lab Mol Endocrinol, BR-04039032 Sao Paulo, BrazilUniv Fed Sao Paulo, Escola Paulista Med, Dept Neurol, Div Endocrinol,Lab Mol Endocrinol, BR-04039032 Sao Paulo, BrazilWeb of ScienceBlackwell Publishing LtdUniversidade Federal de São Paulo (UNIFESP)Silva, Magnus R Dias da [UNIFESP]Cerutti, Janete Maria [UNIFESP]Tengan, Celia Harumi [UNIFESP]Furuzawa, Gilberto Koiti [UNIFESP]Vieira, Teresa C. Alfinito [UNIFESP]Gabbai, Alberto Alain [UNIFESP]Maciel, Rui Monteiro de Barros [UNIFESP]2018-06-15T16:52:47Z2018-06-15T16:52:47Z2002-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion367-375http://dx.doi.org/10.1046/j.1365-2265.2002.01481.xClinical Endocrinology. Oxford: Blackwell Publishing Ltd, v. 56, n. 3, p. 367-375, 2002.10.1046/j.1365-2265.2002.01481.x0300-0664http://repositorio.unifesp.br/handle/11600/43358WOS:000174999400013engClinical Endocrinologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-02T13:59:32Zoai:repositorio.unifesp.br/:11600/43358Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-02T13:59:32Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
title Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
spellingShingle Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
Silva, Magnus R Dias da [UNIFESP]
title_short Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
title_full Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
title_fullStr Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
title_full_unstemmed Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
title_sort Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha 1 subunit gene (Ca(v)1 center dot 1) are not associated with thyrotoxic hypokalaemic periodic paralysis
author Silva, Magnus R Dias da [UNIFESP]
author_facet Silva, Magnus R Dias da [UNIFESP]
Cerutti, Janete Maria [UNIFESP]
Tengan, Celia Harumi [UNIFESP]
Furuzawa, Gilberto Koiti [UNIFESP]
Vieira, Teresa C. Alfinito [UNIFESP]
Gabbai, Alberto Alain [UNIFESP]
Maciel, Rui Monteiro de Barros [UNIFESP]
author_role author
author2 Cerutti, Janete Maria [UNIFESP]
Tengan, Celia Harumi [UNIFESP]
Furuzawa, Gilberto Koiti [UNIFESP]
Vieira, Teresa C. Alfinito [UNIFESP]
Gabbai, Alberto Alain [UNIFESP]
Maciel, Rui Monteiro de Barros [UNIFESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Silva, Magnus R Dias da [UNIFESP]
Cerutti, Janete Maria [UNIFESP]
Tengan, Celia Harumi [UNIFESP]
Furuzawa, Gilberto Koiti [UNIFESP]
Vieira, Teresa C. Alfinito [UNIFESP]
Gabbai, Alberto Alain [UNIFESP]
Maciel, Rui Monteiro de Barros [UNIFESP]
description OBJECTIVE To investigate whether patients with thyrotoxic hypokalaemic periodic paralysis (THPP) have the same molecular defect in the calcium channel gene described in familial hypokalaemic periodic paralysis (FHPP), as the symptoms of both diseases are comparable, we analysed, in patients with THPP, the presence of mutations R528H, R1239H and R1239G on the S-4 voltage-sensing transmembrane segment of the alpha1 subunit of the calcium channel gene (Cav1.1).DESIGN AND PATIENTS Genomic DNA was extracted from peripheral blood from 14 patients with THPP, 13 sporadic cases and one with a family history. An FHPP family was selected as a positive control. The exons bearing the described mutations were amplified by PCR, screened by single-strand conformation polymorphism (SSCP), and further sequenced.MEASUREMENTS THPP was diagnosed both clinically and through laboratory tests, all patients having elevated levels of thyroid hormones (T4, T3 or free T4), suppressed TSH and plasma potassium below 3.5 mmol/l.RESULTS No evidence of the described mutations was found in patients with THPP. Furthermore, we did not detect any mutations in any of the four full S-4 voltage-sensing transmembrane segments of Cav1.1 (DIS4, DIIS4, DIIIS4 and DIVS4) by direct sequencing. However, close to the R528H mutation, we identified two single nucleotide polymorphisms at nucleotides 1551 and 1564 in both familial and sporadic cases with THPP. In addition, we were able to detect the R528H mutation in the DIIS4 transmembrane segment in all members of the FHPP family.CONCLUSION Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. However, polymorphisms in nucleotides 1551 and 1564 in the exon 11 were found in patients with familial hypokalaemic periodic paralysis and thyrotoxic hypokalaemic periodic paralysis in higher frequency than in controls. The polymorphisms identified within the Cav1.1 gene are associated with thyrotoxic hypokalaemic periodic paralysis and represent a novel finding.
publishDate 2002
dc.date.none.fl_str_mv 2002-03-01
2018-06-15T16:52:47Z
2018-06-15T16:52:47Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1046/j.1365-2265.2002.01481.x
Clinical Endocrinology. Oxford: Blackwell Publishing Ltd, v. 56, n. 3, p. 367-375, 2002.
10.1046/j.1365-2265.2002.01481.x
0300-0664
http://repositorio.unifesp.br/handle/11600/43358
WOS:000174999400013
url http://dx.doi.org/10.1046/j.1365-2265.2002.01481.x
http://repositorio.unifesp.br/handle/11600/43358
identifier_str_mv Clinical Endocrinology. Oxford: Blackwell Publishing Ltd, v. 56, n. 3, p. 367-375, 2002.
10.1046/j.1365-2265.2002.01481.x
0300-0664
WOS:000174999400013
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical Endocrinology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 367-375
dc.publisher.none.fl_str_mv Blackwell Publishing Ltd
publisher.none.fl_str_mv Blackwell Publishing Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268371485589504